Arbutus Biopharma Corp (ABUS) — Working Capital to Net Assets Ratio

Latest as of December 2025: 115.5%

Arbutus Biopharma Corp (ABUS) has a Working Capital to Net Assets ratio of 115.5% as of December 2025. Working capital of $88.45 Million (current assets of $94.46 Million minus current liabilities of $6.01 Million) is measured against net assets of $76.58 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See net asset quality index of Arbutus Biopharma Corp to measure how much of total assets are equity-financed.

WC/NA Ratio

115.5%
Working Capital / Net Assets

Working Capital

$88.45 Million
USD

Current Assets

$94.46 Million
USD

Current Liabilities

$6.01 Million
USD

Arbutus Biopharma Corp Working Capital to Net Assets (1998–2025)

This chart shows how Arbutus Biopharma Corp's Working Capital to Net Assets ratio has evolved across 28 annual periods from 1998 to 2025. As of December 2025, the ratio stands at 115.5%, reflecting working capital of $88.45 Million against net assets of $76.58 Million USD. Check ABUS goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Annual Working Capital to Net Assets for Arbutus Biopharma Corp (1998–2025)

The table below presents the year-by-year Working Capital to Net Assets ratio for Arbutus Biopharma Corp from 1998 to 2025, covering 28 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see ABUS market cap.

Year WC/NA Ratio Working Capital (USD) Net Assets Current Assets Current Liabilities Change (pp)
2025 115.5% $88.45 Million $76.58 Million $94.46 Million $6.01 Million ▲ +0.8 pp
2024 114.7% $111.70 Million $97.37 Million $127.32 Million $15.62 Million ▲ +11.4 pp
2023 103.3% $109.54 Million $106.02 Million $132.03 Million $22.49 Million ▲ +16.9 pp
2022 86.4% $118.28 Million $136.85 Million $151.14 Million $32.86 Million ▼ -1.8 pp
2021 88.2% $149.44 Million $169.44 Million $160.66 Million $11.22 Million ▼ -27.7 pp
2020 115.9% $118.16 Million $101.97 Million $127.70 Million $9.54 Million ▼ -2.3 pp
2019 118.2% $86.00 Million $72.74 Million $93.83 Million $7.83 Million ▲ +59.3 pp
2018 58.9% $117.99 Million $200.23 Million $129.23 Million $11.24 Million ▼ -5.5 pp
2017 64.4% $117.50 Million $182.50 Million $129.40 Million $11.90 Million ▲ +4.3 pp
2016 60.1% $122.00 Million $203.00 Million $132.60 Million $10.60 Million ▲ +28.5 pp
2015 31.6% $173.30 Million $547.68 Million $183.88 Million $10.58 Million ▼ -84.3 pp
2014 115.9% $102.00 Million $88.00 Million $116.40 Million $14.40 Million ▲ +18.2 pp
2013 97.7% $57.82 Million $59.19 Million $70.34 Million $12.52 Million ▼ -0.8 pp
2012 98.5% $40.29 Million $40.92 Million $51.25 Million $10.96 Million ▲ +8.0 pp
2011 90.5% $4.71 Million $5.21 Million $11.55 Million $6.84 Million ▼ -0.6 pp
2010 91.1% $9.77 Million $10.73 Million $17.91 Million $8.13 Million ▲ +39.5 pp
2009 51.6% $18.28 Million $35.44 Million $24.79 Million $6.51 Million ▼ -9.2 pp
2008 60.8% $23.28 Million $38.29 Million $27.33 Million $4.05 Million ▼ -30.8 pp
2007 91.6% $16.83 Million $18.37 Million $23.29 Million $6.46 Million ▲ +271.2 pp
2006 -179.5% $-279.25K $155.53K $5.53 Million $5.81 Million ▼ -132.4 pp
2005 -47.1% $8.71 Million $-18.49 Million $10.92 Million $2.21 Million ▲ +122.9 pp
2004 -170.0% $17.85 Million $-10.50 Million $28.73 Million $10.88 Million ▼ -252.0 pp
2003 82.0% $35.56 Million $43.38 Million $40.10 Million $4.53 Million ▲ +6.8 pp
2002 75.2% $34.09 Million $45.35 Million $38.89 Million $4.80 Million ▼ -1.6 pp
2001 76.8% $47.20 Million $61.49 Million $49.78 Million $2.58 Million ▼ -0.9 pp
2000 77.7% $23.32 Million $30.03 Million $25.23 Million $1.91 Million ▲ +7.4 pp
1999 70.3% $18.89 Million $26.88 Million $20.22 Million $1.32 Million ▲ +28.8 pp
1998 41.5% $5.99 Million $14.43 Million $6.82 Million $830.41K
pp = percentage points